Isomorphic Labs

DeepMind spinout applying AlphaFold-style AI to drug design

Paid Drug Discovery
Visit Tool →

// about Isomorphic Labs

Isomorphic Labs is Alphabet's drug discovery company, built on the protein-structure prediction work behind AlphaFold and extended to design new molecules against disease targets directly. Rather than selling software, it runs its own drug programs and partners with pharma companies like Eli Lilly and Novartis to apply its models to their pipelines. It's one of the clearest examples of a major AI research lab moving from predicting biology to designing medicines.